2011Journal of Chinese Practical Diagnosis and TherapyRequires access

Expression of leukemic stem cell associated membrane antigens in acute leukemia cells

Ping Xiao

Open publisher page 0 citations

Abstract

Objective To study the expression of leukemic stem cell associated membrane antigens in acute leukemia cells with different subtypes.Methods Leukemic stem cell associated membrane antigens CD96,CD90,CD123 and CD71 were detected with flow cytometry in 50 acute leukemia patients with different subtypes including acute myeloblast leukemia without cell maturation(M1),acute myeloblast leukemia with cell maturation(M2),acute promyelocytic leukemia(M3),acute myelomonocytic leukemia(AMML) and B-acute lymphoblastic leukemia(B-ALL).Results The positive rate of CD96 expression in M3(90.00%) was significantly higher than that in M2(18.18%) and B-ALL(20.00%)(P0.05).The up-regulation of CD123 was identified in all acute leukemia,and there was no significance difference in the subtypes(P0.05).The positive rate of CD71 expression in four subtypes of acute myeloid leukemia(M1,M2,M3 and M4) was 80.00%,72.73%,90.00% and 100.00% respectively,all of which were significantly higher than those in B-ALL(20%)(P0.05).There was no significant difference in CD90 expression between B-ALL(13.33%) and acute myeloid leukemia(P0.05).Conclusion CD96 may become a marker for acute myeloid leukemia and its high expression might contribute to the overgrowth of acute myeloid leukemia cells.CD71 also may become a marker to distinguish acute myeloid leukemia from acute lymphoblastic leukemia for its higher expression in acute myeloid leukemia.

About this research paper

What this paper is about

Objective To study the expression of leukemic stem cell associated membrane antigens in acute leukemia cells with different subtypes.Methods Leukemic stem cell associated membrane antigens CD96,CD90,CD123 and CD71 were detected with flow cytometry in 50 acute leukemia patients with different subtypes including acute myeloblast leukemia without cell maturation(M1),acute myeloblast leukemia with cell maturation(M2),acute promyelocytic leukemia(M3),acute myelomonocytic leukemia(AMML) and B-acute lymphoblastic leukemia(B-ALL).Results The positive rate of CD96 expression in M3(90.00%) was significantly higher than that in M2(18.18%) and B-ALL(20.00%)(P0.05).The up-regulation of CD123 was identified in all acute leukemia,and there was no significance difference in the subtypes(P0.05).The positive rate of CD71 expression in four subtypes of acute myeloid leukemia(M1,M2,M3 and M4) was 80.00%,72.73%,90.00% and 100.00% respectively,all of which were significantly higher than those in B-ALL(20%)(P0.05).There was no significant difference in CD90 expression between B-ALL(13.33%) and acute myeloid leukemia(P0.05).Conclusion CD96 may become a marker for acute myeloid leukemia and its high expression might contribute to the overgrowth of acute myeloid leukemia cells.CD71 also may become a marker to distinguish acute myeloid leukemia from acute lymphoblastic leukemia for its higher expression in acute myeloid leukemia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the expression of leukemic stem cell associated membrane antigens in acute leukemia cells with different subtypes.Methods Leukemic stem cell associated membrane antigens CD96,CD90,CD123 and CD71 were detected with flow cytometry in 50 acute leukemia patients with different subtypes including acute myeloblast leukemia without cell maturation(M1),acute myeloblast leukemia with cell maturation(M2),acute promyelocytic leukemia(M3),acute myelomonocytic leukemia(AMML) and B-acute lymphoblastic leukemia(B-ALL).Results The positive rate of CD96 expression in M3(90.00%) was significantly higher than that in M2(18.18%) and B-ALL(20.00%)(P0.05).The up-regulation of CD123 was identified in all acute leukemia,and there was no significance difference in the subtypes(P0.05).The positive rate of CD71 expression in four subtypes of acute myeloid leukemia(M1,M2,M3 and M4) was 80.00%,72.73%,90.00% and 100.00% respectively,all of which were significantly higher than those in B-ALL(20%)(P0.05).There was no significant difference in CD90 expression between B-ALL(13.33%) and acute myeloid leukemia(P0.05).Conclusion CD96 may become a marker for acute myeloid leukemia and its high expression might contribute to the overgrowth of acute myeloid leukemia cells.CD71 also may become a marker to distinguish acute myeloid leukemia from acute lymphoblastic leukemia for its higher expression in acute myeloid leukemia.

Key concepts: Myeloid leukemia, Medicine, Leukemia, Acute leukemia, Acute promyelocytic leukemia, Acute myelomonocytic leukemia, CD135, Myeloid

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of leukemic stem cell associated membrane antigens in acute leukemia cells — Research Paper | ScholarLens